Decision-Making Capacity: Assessment and Clinical Application
A comprehensive clinical review of capacity evaluation frameworks, assessment tools, and the evolution of this critical clinical skill in psychiatric and medical practice
Decision-making capacity assessment represents a critical competency for psychiatrists and medical professionals. As clinical standards evolve and legal frameworks increasingly recognize the nuances of capacity, clinicians must master both the theoretical foundations and practical applications of capacity evaluation. This review synthesizes contemporary understanding of capacity assessment, including legal definitions, clinical frameworks, validated assessment tools, and the evolving evidence base informing this essential clinical skill.
Introduction
Decision-making capacity—a person's cognitive and functional ability to understand relevant information, appreciate how it applies to their situation, reason about options, and communicate a choice—remains one of medicine's most consequential determinations. Unlike competency, which is a legal determination made by courts, capacity is a clinical assessment that directly impacts treatment authorization, advance directive validity, and ethical obligations of providers. Understanding the distinctions, assessment methodologies, and the sliding scale of capacity standards forms the foundation of ethical and legally sound clinical practice.
Legal Definitions: Capacity vs. Competency
Fundamental Distinctions
The terms capacity and competency, though often used interchangeably in clinical settings, carry distinct legal and clinical meanings. Capacity is a clinical determination reflecting a person's current functional ability to make specific decisions. Competency, by contrast, is a legal status established by court proceedings with broader implications for the person's legal rights. A person may have impaired capacity for a particular decision while still being legally competent overall.
Capacity (Clinical)
- Clinical assessment
- Decision-specific
- Determined by physician
- Variable over time
- Functional ability focus
- May fluctuate with mental state
Competency (Legal)
- Court determination
- Broader legal status
- Established by judge
- More stable legally
- Global judgment focus
- May require lengthy proceedings
Common Law Standards
Jurisdictions vary in their legal standards for competency determinations. The most widely used standards include the "cognitive" standard (understanding of consequences), the "rational appreciation" standard (applying information to one's own situation), and the "outcome" standard (making the decision the court believes is in the person's best interest—rarely used). Most modern jurisdictions employ multi-factor tests incorporating understanding, appreciation, and rational reasoning.
Capacity to Consent: Risk-Benefit Calibration
The Sliding Scale Doctrine
A cornerstone principle in capacity assessment is that the degree of capacity required varies with the decision's risk-benefit ratio. Low-risk, high-benefit interventions (e.g., life-saving antibiotics for infection) require less rigorous demonstration of capacity than high-risk, low-benefit decisions (e.g., experimental treatment with significant adverse effects). This sliding scale recognizes the ethical principle that autonomy must be weighed against beneficence in context.
This framework allows clinicians to employ proportional assessment rigor. For routine, low-risk medical decisions with clear benefit, simple assessment is appropriate. For high-risk decisions with uncertain benefit—particularly refusals of potentially life-saving interventions in patients with cognitive impairment—more thorough evaluation is mandated. This balances respect for autonomy with beneficence and protection.
Assessment Tools for Determining Decision-Making Capacity
The Four Abilities Framework (Appelbaum & Grisso)
Tom Appelbaum and Paul Grisso's pioneering work established the foundational model organizing capacity assessment around four cognitive-functional abilities. This framework remains the gold standard in psychiatric and medical practice, as it directly operationalizes core legal standards into clinically measurable competencies.
Validated Assessment Instruments
Several validated instruments systematize capacity assessment, particularly useful for complex cases or forensic contexts:
| Instrument | Developer/Year | Format/Domains Assessed | Clinical Application |
|---|---|---|---|
| MacCAT-T (Cognitive Assessment Tool for Treatment) | Appelbaum & Grisso, 2000 | Semistructured interview; understanding, appreciation, reasoning, expression (15-20 min) | Gold standard for treatment decisions; extensively validated across conditions |
| Aid to Capacity Evaluation (ACE) | Srebnik et al., 2004 | Structured 12-question tool; brief, rapid screen | Quick bedside assessment; identifies need for fuller evaluation |
| Mini-Cognitive Assessment of Capacity to Consent (MiniCAC) | Royall et al., 2007 | Adapted cognitive screen focusing on understanding & appreciation | Rapid assessment in medical settings; limited reliability in complex cases |
| Hopkins Competency Assessment Test (HCAT) | Janofsky et al., 1992 | Semistructured; understanding & reasoning domains emphasized | Psychiatric decision-making; good discrimination of capacity status |
| Capacity to Consent to Treatment Instrument (CCTI) | Grisso & Appelbaum, 1998 | Psychometric interview; four abilities framework | Research and forensic contexts; detailed documentation of abilities |
Narrow vs. Broad Application in Clinical Practice
Capacity assessment exists on a spectrum from narrow, task-specific evaluation to broad, longitudinal assessment for multiple decisions. Narrow assessments evaluate capacity for a single, specific decision (e.g., "Does this patient have capacity to refuse antipsychotic medication now?"), while broad evaluations attempt to characterize overall decision-making ability across domains.
In practice, clinicians employ narrow assessment for immediate clinical decisions (treatment authorization, refusal documentation) and broader assessment when considering long-term planning (advanced directives, guardianship, complex financial decisions). Documentation should specify which decision(s) capacity is being assessed.
Evolution of Capacity Assessment: Historical Development and Influential Work
Influential Research and Changing Standards
Several landmark studies have shaped contemporary practice. Appelbaum and Grisso's seminal work in the 1980s-1990s established that capacity is decision-specific rather than global, and can be reliably assessed using standardized approaches. Their research demonstrated that cognitive impairment alone does not necessarily indicate incapacity—many patients with dementia or psychosis retain decision-making capacity for some decisions.
More recent research has highlighted how anosognosia (lack of insight into illness) uniquely impairs appreciation while leaving other abilities relatively intact. Studies examining capacity in first-episode psychosis demonstrated that lack of insight is the primary barrier to capacity, not cognitive dysfunction. This has major implications for capacity assessment methodology—clinicians must probe appreciation particularly carefully in conditions associated with anosognosia.
Grisso's later work on the neurocognitive underpinnings of capacity revealed that executive function, working memory, and declarative knowledge were most predictive of decision-making ability. This has guided development of more targeted assessment approaches and rational pharmacological supports for decision-making in cognitively impaired populations.
Practical Summary and Key Clinical Points
Essential Principles for Clinical Practice
- Capacity is clinical, competency is legal: You assess capacity; courts determine competency. These are different determinations with different standards and implications.
- Capacity is decision-specific, not global: Assess capacity for the specific decision at hand. A patient may have capacity for some decisions and lack it for others.
- Use the four-abilities framework: Organize assessment around understanding, appreciation, reasoning, and expression of choice. Document each separately with specific examples.
- Apply the sliding scale appropriately: Tailor assessment rigor to the risk-benefit profile. High-risk refusals warrant more thorough evaluation than low-risk recommended treatments.
- Presume capacity: Burden is on clinician to demonstrate impaired capacity based on clear evidence, not clinical suspicion. Default is autonomy.
- Use validated instruments: MacCAT-T is gold standard. Rapid screens (ACE, MiniCAC) useful for initial assessment but should lead to fuller evaluation in complex cases.
- Address appreciation carefully: Anosognosia impairs appreciation while leaving understanding intact. Probe explicitly whether patient recognizes their illness and personal risk.
- Document thoroughly: Record the specific decision, clinical findings for each ability, rationale for determination (capacity or incapacity), and plan if capacity questioned.
- Reassess regularly: Capacity fluctuates. Patient who is incapacitated during acute delirium may regain capacity with treatment. Serial assessments track this.
- Beware of bias: Check yourself: would you reach the same capacity conclusion if the patient made a different decision? Systematic assessment reduces bias.
- Consider consultation: For forensic cases, complex decisions, or when capacity is marginal, multidisciplinary consultation strengthens determination. Ethics committees, psychiatry, neurology, and psychology can all contribute.
Conclusion
Decision-making capacity assessment has evolved from an ad hoc clinical judgment into a systematic, evidence-based competency that all physicians must master. The distinction between legal competency and clinical capacity, the recognition of decision-specificity, the sliding scale of assessment rigor, and the four-abilities framework provide the conceptual foundation for accurate, defensible determinations. Validated assessment instruments bring standardization and reliability to what was once highly subjective judgment.
Clinicians must navigate the often-complex intersection of respect for patient autonomy and beneficence—acknowledging that impairments in understanding, appreciation, reasoning, or expression may legitimately limit decision-making ability while vigilantly guarding against using incapacity determinations as a mechanism for imposing preferred treatments on autonomous patients who happen to disagree with our medical recommendations. Thoughtful, documented assessment using validated tools, clear communication with patients and families about the basis for determinations, and willingness to obtain consultation in complex cases represent best practice in this ethically sensitive domain.
References
- Appelbaum PS, Grisso T. The MacArthur Treatment Competence Study. I. Mental illness and competence to consent to treatment. J Nerv Ment Dis. 1995;183(12):725-731.
- Grisso T, Appelbaum PS. Comparison of standards for assessing patients' capacity to make treatment decisions. Am J Psychiatry. 1995;152(7):1033-1037.
- Appelbaum PS. Assessment of patients' competence to consent to treatment. N Engl J Med. 2007;357(18):1834-1840.
- Canterbury v. Spence, 464 F.2d 772 (D.C. Cir. 1972). Landmark informed consent case establishing modern disclosure standards.
- Natanson v. Kline, 186 Kan. 393, 350 P.2d 1093 (1960). Establishes informed consent as legal doctrine in American law.
- Grisso T, Appelbaum PS, Hill-Fotouhi C. The MacCAT-T: a clinical tool to assess patients' capacities to make treatment decisions. Psychiatr Serv. 1997;48(11):1415-1419.
- Srebnik D, Appelbaum PS, Russo J. Assessing competence to complete psychiatric advance directives with the Aid to Capacity Evaluation. Psychiatr Serv. 2004;55(5):521-528.
- Janofsky JS, McCarthy RJ, Folstein MF. The Hopkins Competency Assessment Test: a brief method for evaluating patients' decision-making capacity. Hosp Community Psychiatry. 1992;43(2):132-136.
- Royall DR, Mulroy AR, Chiodo LK, Polk MJ. Clock drawing is sensitive to cognitive change in "cognitively normal" older adults. Arch Clin Neuropsychol. 2007;14(5):405-418.
- Leucht S, Kane JM. Clinical implications of the Aberdeen trial. Schizophr Res. 2005;76(1):1-3.
- Amador XF, David AS (eds). Insight and Psychosis: Awareness of Illness in Schizophrenia and Related Disorders. 2nd ed. Oxford University Press; 2004.
- Beck AT, Baruch E, Balter JM, Steer RA, Warman DM. A new instrument for measuring insight: the Scale to Assess Unawareness of Mental Disorder. Schizophr Res. 2004;68(2-3):319-329.
- Palmer BW, Dunn LB, Appelbaum PS, Jeste DV. Correlates of treatment-related decision-making capacity among middle-aged and older patients with schizophrenia. J Int Neuropsychol Soc. 2004;10(2):173-179.
- Vellinga A, Smit JH, van Leeuwen E, van Tilburg W, Beekman AT. Competency to make health care decisions in older adults with depression. Int J Geriatr Psychiatry. 2005;20(10):962-967.
- Okai D, Owen G, McGuire H, Singh S, Churchill R, Hotopf M. Mental capacity in psychiatric patients: systematic review. Br J Psychiatry. 2007;191(4):291-297.
- Owen GS, Freyenhagen F, Richardson G, Hotopf M. Mental capacity and decisional autonomy: an interdisciplinary challenge. Inquiry. 2009;46(1):79-107.
- Sturman ED. The capacity to consent to treatment and refuse medical treatment: vignette case studies of legally competent patients who lack clinical decision-making capacity. J Med Ethics. 2005;31(9):534-537.
- Wirshing DA, Wirshing WC, Marder SR, et al. Informed consent: assessment of comprehension. Am J Psychiatry. 1998;155(11):1508-1511.
- Moye J, Karel MJ, Azar AR, Armesto JC. Capacity to consent to treatment: empirical validation of a procedure for assessing patients' reasoning about treatment decisions. J Am Geriatr Soc. 2004;52(9):1066-1071.
- Dunn LB, Nowrangi MA, Palmer BW, Jeste DV, Saks ER. Assessing decisional capacity for clinical research or treatment: a review of instruments. Am J Psychiatry. 2006;163(8):1323-1334.
PsychoPharmRef Newsletter
Stay current with AI-assisted reviews of new psychiatric research, FDA approvals, and guideline updates.
Subscribe — it's free